z-logo
open-access-imgOpen Access
ADVANCED EPIDEMIC KAPOSI'S SARCOMA (EKS) : DOXORUBICIN-BLEOMYCIN-VINCRISTINE (ABV) TREATMENT IS AN ACCEPTABLE ALTERNATIVE IN PATIENTS FROM UNDER-DEVELOPED COUNTRIES
Author(s) -
Dimas Hernández,
María Elena Marín,
José Ricardo Pérez
Publication year - 1999
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00126334-199905010-00080
Subject(s) - bleomycin , vincristine , doxorubicin , sarcoma , medicine , virology , oncology , chemotherapy , pathology , cyclophosphamide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here